FindTrial
Sign In

The Impact of Traditional Chinese Medicine Exposure on Survival in Patients with Ovarian Cancer and the Construction of a Predictive Model: A Retrospective Real-World Study

The Impact of Traditional Chinese Medicine Exposure on Survival in Patients with Ovarian Cancer and the Construction of a Predictive Model: A Retrospective Real-World Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000747
Enrollment
Unknown
Registered
2026-03-27
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

TCM Expose:Traditional Chinese Medicine-related treatments (including herbal decoctions, proprietary Chinese medicines, acupuncture, etc.)
TCM non-exposure:Standard Western medical diagnosis and treatment

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Patients with a postoperative pathological diagnosis confirming malignant ovarian tumors; (2) Age = 18 years; (3) Complete follow-up data available in the inpatient or outpatient medical record system.

Exclusion criteria

Exclusion criteria: (1) History of other malignancies; (2) Pregnant or lactating women; (3) Patients with severely incomplete or insufficient original data.

Design outcomes

Primary

MeasureTime frame
progression-free survival;—

Secondary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactJing Xiao

The Second Affiliated Hospital of Guangzhou University of Chinese

xiaojingson_2004@126.com13556148318

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026